Zhiyi Pharmaceutics

China
Guangzhou, Guangdong, China, 510530

Company profile

Zhiyi Pharmaceutics company profile

Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and the innovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains.

Business identity

Contact email
[email protected]
Phone number
020-82258826
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2013-01-01, Year

Headquarters

Postal code
510530
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$82.7M
Last funding
Series C / $13.8M / 2024-03-28
Last equity funding
Series C / $13.8M
Investors
11
Lead investors
1
Founders
1

Founders and investors

Founders

Ye Wang

Lead investors

Guangdong Technology Financial Group

Investors

Guangdong Technology Financial GroupKorea Investment HoldingsSDIC Venture CapitalShenzhen Capital GroupSinoking Capital